The cobas® SARS-CoV-2 Test provides reliable and high-quality results for clinical decision-making for the improved management of COVID-19 patients and to reduce the risk of SARS-CoV-2 (coronavirus) infection. Healthcare professionals use these tests to assess if patients are at risk of developing disease by this pathogen, which can contribute to severe upper respiratory distress, complications, and potential death. The tests are for use on the automated cobas® 6800/8800.
The product has received US-FDA emergency use authorisation and CE mark. In India, CDSCO approval is issued due to an emergency health situation in the public interest.